Q3 2021 13F Holders as of 30 Sep 2021
-
Type / Class
-
Equity / Common Stock, $0.01 par value
-
Shares outstanding
-
28,234,434
-
Number of holders
-
68
-
Total 13F shares, excl. options
-
5,487,089
-
Shares change
-
+164,655
-
Total reported value, excl. options
-
$97,479,919
-
Value change
-
+$2,463,812
-
Put/Call ratio
-
78.6%
-
Number of buys
-
34
-
Number of sells
-
-36
-
Price
-
$17.75
Significant Holders of ClearPoint Neuro, Inc. - Common Stock, $0.01 par value (CLPT) as of Q3 2021
94 filings reported holding CLPT - ClearPoint Neuro, Inc. - Common Stock, $0.01 par value as of Q3 2021.
ClearPoint Neuro, Inc. - Common Stock, $0.01 par value (CLPT) has 68 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 5,487,089 shares
of 28,234,434 outstanding shares and own 19.43% of the company stock.
Largest 10 shareholders include BlackRock Inc. (1,163,572 shares), VANGUARD GROUP INC (861,473 shares), ROYCE & ASSOCIATES LP (614,507 shares), STATE STREET CORP (310,871 shares), GEODE CAPITAL MANAGEMENT, LLC (291,836 shares), GUARDIAN POINT CAPITAL, LP (230,000 shares), FRED ALGER MANAGEMENT, LLC (190,391 shares), Taylor Frigon Capital Management LLC (176,264 shares), NORTHERN TRUST CORP (167,655 shares), and Parian Global Management LP (153,950 shares).
This table shows the top 68 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.